| HOME >> BIOLOGY >> TECHNOLOGY |
mpared to $69.8 million for the nine months ended September 30, 2007, an increase of 47.7%;
-- Net income was $19.3 million, or $0.37 per diluted share, for the nine months ended September 30, 2008 compared to net income of $10.1 million, or $0.20 per diluted share, for the nine months ended September 30, 2007, an increase of 91.6%;
-- Bookings for the nine months ended September 30, 2008 were $142.1 million, which are $3.4 million higher than the bookings of $138.6 recorded for the entire year 2007;
-- The Company's gross margin percentage for the nine months ended September 30, 2008 was 55.3% compared to 49.9% for the nine months ended September 30, 2007. Operating income margin for the nine months ended September 30, 2008 was 28.9% compared to 21.1% for the nine months ended September 30, 2007;
-- Revenues from acquired backlog of CCSS were $8.2 million and cost of revenues were $7.2 million for the nine months ended September 30, 2008. Operating income during this period included a loss of $2.2 million from the operations of CCSS and the integration of CCSS into eRT;
-- The Company's tax rate was 37.1% for the nine months ended September 30, 2008 compared to 38.5% for the nine months ended September 30, 2007; and
-- For the nine months ended September 30, 2008, cash provided by operating activities was $26.8 million.
"We continue to be pleased with our results through the third quarter
of 2008," commented Dr. Michael McKelvey, President and CEO of eRT. "Our
$33.9 million of revenue for the third quarter reflected the expected
sequential decrease from our record $35.5 million in the second quarter
2008 due to slower activity in the summer months and a working down of the
CCSS backlog. Through the nine months ending September 30, 2008, revenue,
bookings, and net income have all exceeded the levels achieved in all of
2007. As an example, net income through the first nine months of 2008 was
26.8% higher than in the en
'/>"/>
| SOURCE eResearchTechnology, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
2. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
3. eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
4. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
5. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
6. eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008
7. eResearchTechnology to Present at the Deutsche Bank 33rd Annual Healthcare Conference on May 7th 2008
8. eResearchTechnology Reports First Quarter 2008 Results
9. eResearchTechnology Announces Resignation of its CFO
10. eResearchTechnology to Present at the FBR 12th Annual Spring Investor Conference on May 28th 2008
11. eResearchTechnology Names New Chief Financial Officer
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |